Investeringsforeningen Nykredit Invest Balance
Investeringsforeningen Nykredit Invest Balance - Ophævelse af suspension
Investeringsforeningen Nykredit Invest Balance - Ophævelse af suspension
I fortsættelse af tidligere meddelelse d. 09. januar 2025 skal det herved oplyses, at det nu igen er muligt at stille indre værdier i nedenstående afdelinger, hvorfor Nykredit Portefølje Administration A/S har anmodet Nasdaq Copenhagen A/S om, at suspension ophæves.
Ophævelsen gælder nedenstående afdelinger:
| ISIN | Fund Name | Order Book Code |
| DK0061671013 | Bæredygtig Defensiv KL | NBIBDKL |
| DK0061671286 | Bæredygtig Moderat KL | NBIBMKL |
| DK0061671369 | Bæredygtig Offensiv KL | NBIBOKL |
| DK0016188733 | Defensiv KL | NBIDEKL |
| DK0016188816 | Moderat KL | NBIMOKL |
| DK0060441749 | Offensiv KL | NBIOFKL |
Eventuelle spørgsmål vedrørende denne meddelelse kan rettes til npa.pm@nykredit.dk eller JNA@nykredit.dk
Med venlig hilsen
Nykredit Portefølje Administration A/S
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Sveriges Riksbank10.1.2025 16:20:00 CET | Press release
CONDITIONS FOR RIKSBANK AUCTIONS GOVERNMENT BONDS
Alm. Brand A/S10.1.2025 16:05:30 CET | Press release
Alm. Brand Tier-2 Bonds
ABN AMRO10.1.2025 15:28:40 CET | Press release
ABN AMRO Bank intends to propose Marguerite Bérard as new CEO
Terranet10.1.2025 14:30:00 CET | Press release
Terranet announces Lars Lindell as new CEO
Teva Pharmaceutical Industries Ltd; Samsung Bioepis Co., Ltd.10.1.2025 14:30:00 CET | Press release
Samsung Bioepis and Teva Enter into a Strategic Partnership for Commercialization of EPYSQLI® (eculizumab-aagh) in the United States
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom